Tetracosactide hexacetaat ( DrugBank: Tetracosactide )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 222 | Primary nephrotic syndrome | 1 |
222. Primary nephrotic syndrome
Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00694863 (ClinicalTrials.gov) | July 2008 | 9/6/2008 | Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy | Treatment With Synthetic Adrenocorticotropic Hormone (ACTH) in Patients With Membranous Nephropathy and High Risk for Renal Failure. A Pilot Study | Idiopathic Membranous Nephropathy | Drug: tetracosactide hexacetaat | Radboud University | Dutch Kidney Foundation | Completed | 18 Years | 95 Years | Both | 20 | Phase 2 | Netherlands |